ConductScience.org, home
common wart
API referenceFor AI assistants

Disease · MONDO_0001209

Comparisons in its trials17

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

1 to 17 of 17

Download this page as JSON
ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
Active vs Vehicle: deaths from any cause0 of 2540 of 249503NCT03687372Trial comparisons
Active vs Vehicle: serious adverse events1 of 2541 of 249503NCT03687372Trial comparisons
Active vs Vehicle: deaths from any cause0 of 2510 of 251502NCT03691831Trial comparisons
Active vs Vehicle: serious adverse events1 of 2512 of 251502NCT03691831Trial comparisons
CLS006 (Furosemide) vs Vehicle: deaths from any cause0 of 2460 of 238484NCT02971891Trial comparisons
CLS006 (Furosemide) vs Vehicle: serious adverse events0 of 2460 of 238484NCT02971891Trial comparisons
A-101 45% (Active) vs Isopropyl Alcohol and Water (Vehicle): Proportion of Subjects With Treatment Emergent AEs After Application of A-101 45% for the Treatment of Common Warts70 of 163116 of 213376NCT03812510Trial comparisons
Hydrogen Peroxide 45% A-101 vs Isopropyl Alcohol and Water Vehicle: Number of Subjects With a Single Wart at Baseline Whose Wart Was Clear on the PWA Scale Between Active and Vehicle Group (PWA=0) at Visit 10 (Day 60)
33 of 16210 of 141303NCT03687372Trial comparisons
Active vs Vehicle: Number of Subjects With a Single Wart at Baseline Whose Wart Was Clear on the PWA Scale Between Active and Vehicle Group (PWA=0) at Visit 10 (Day 60)19 of 1264 of 142268NCT03691831Trial comparisons
Active vs Vehicle: deaths from any cause0 of 810 of 78159NCT03278028Trial comparisons
Active vs Vehicle: serious adverse events0 of 810 of 78159NCT03278028Trial comparisons
Active vs Vehicle: deaths from any cause0 of 780 of 79157NCT03210337Trial comparisons
Active vs Vehicle: serious adverse events3 of 781 of 79157NCT03210337Trial comparisons
Measles, Mumps, Rubella Vaccine vs Vitamin D3: deaths from any cause0 of 310 of 3061NCT04428359Trial comparisons
Measles, Mumps, Rubella Vaccine vs Vitamin D3: serious adverse events0 of 316 of 3061NCT04428359Trial comparisons
Cohort 1 vs Cohort 2: serious adverse events0 of 210 of 3556NCT03487549Trial comparisons
Cohort 1 vs Cohort 2: deaths from any cause0 of 210 of 3455NCT03487549Trial comparisons

diseases-2026-09-18-0.1.0

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0001209/comparisons

API referenceFor AI assistants